Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: A focused review

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  Sheng, Juan Juan ^a   Jin, Jian Ping ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac muscle; Cardiomyopathy; Isoforms; Myofilament proteins; Posttranslational modification

Indexed keywords

CALCIUM; TROPOMYOSIN; TROPONIN; TROPONIN C; TROPONIN I; TROPONIN T;

ADAPTATION; ALTERNATIVE RNA SPLICING; CONGESTIVE CARDIOMYOPATHY; GENE CONTROL; GENE MUTATION; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RESTRICTIVE CARDIOMYOPATHY; REVIEW; STRUCTURE ACTIVITY RELATION; THIN FILAMENT;

EID: 84901020970     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00165     Document Type: Review

References (200)

1. 2+ sensitivity of skinned cardiac muscle contractility coincident with troponin T-band shifts in the diabetic rat. Circ. Res. 76, 600-606. doi: 10.1161/01.RES.76.4.600
2. Akhter, S., Bueltmann, K. Jr., Huang, X., and Jin, J. P. (2014). Restrictive cardiomyopathy mutations demonstrate functions of the C-terminal end-segment of troponin I. Arch. Biochem. Biophys. doi: 10.1016/j.abb.2013.12.001. [Epub ahead of print].
3. Akhter, S., Zhang, Z., Jin, J. P. (2012). The heart-specific NH2-terminal extension regulates the molecular conformation and function of cardiac troponin I. Am. J. Physiol. Heart Circ. Physiol. 302, H923-H933. doi: 10.1152/ajpheart.00637.2011
4. Anderson, P. A., Greig, A., Mark, T. M., Malouf, N. N., Oakeley, A. E., Ungerleider, R. M., et al. (1995). Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ. Res. 76, 681-686. doi: 10.1161/01.RES.76.4.681
5. Anderson, P. A., Malouf, N. N., Oakeley, A. E., Pagani, E. D., and Allen, P. D. (1991). Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ. Res. 69, 1226-1233. doi: 10.1161/01.RES.69.5.1226
6. Anderson, P. A., Malouf, N. N., Oakeley, A. E., Pagani, E. D., and Allen, P. D. (1992). Troponin T isoform expression in the normal and failing human left ventricle: a correlation with myofibrillar ATPase activity. Basic Res. Cardiol. 87(Suppl. 1), 117-127.
7. Arteaga, G. M., Palmiter, K. A., Leiden, J. M., and Solaro, R. J. (2000). Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J. Physiol. 526(Pt 3), 541-549. doi: 10.1111/j.1469-7793.2000.t01-1-00541.x
8. Barbato, J. C., Huang, Q. Q., Hossain, M. M., Bond, M., and Jin, J. P. (2005). Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function. J. Biol. Chem. 280, 6602-6609. doi: 10.1074/jbc.M408525200
9. 2+ sensitivity and cross-bridge cycling. J. Biol. Chem. 285, 5674-5682. doi: 10.1074/jbc.M109.066456
10. Belin, R. J., Sumandea, M. P., Allen, E. J., Schoenfelt, K., Wang, H., Solaro, R. J., et al. (2007). Augmented protein kinase C-a-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ. Res. 101, 195-204. doi: 10.1161/CIRCRESAHA.107.148288
11. Biesiadecki, B. J., Chong, S. M., Nosek, T. M., and Jin, J. P. (2007a). Troponin T core structure and the regulatory NH2-terminal variable region. Biochemistry 46, 1368-1379. doi: 10.1021/bi061949m
12. Biesiadecki, B. J., Elder, B. D., Yu, Z. B., and Jin, J. P. (2002). Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J. Biol. Chem. 277, 50275-50285. doi: 10.1074/jbc.M206369200
13. Biesiadecki, B. J., and Jin, J. P. (2002). Exon skipping in cardiac troponin T of turkeys with inherited dilated cardiomyopathy. J. Biol. Chem. 277, 18459-18468. doi: 10.1074/jbc.M200788200
14. Biesiadecki, B. J., Kobayashi, T., Walker, J. S., John Solaro, R., and De Tombe, P. P. (2007b). The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ. Res. 100, 1486-1493. doi: 10.1161/01.RES.0000267744.92677.7f
15. Biesiadecki, B. J., Schneider, K. L., Yu, Z. B., Chong, S. M., and Jin, J. P. (2004). An R111C polymorphism in wild turkey cardiac troponin I accompanying the dilated cardiomyopathy-related abnormal splicing variant of cardiac troponin T with potentially compensatory effects. J. Biol. Chem. 279, 13825-13832. doi: 10.1074/jbc.M314225200
16. Biesiadecki, B. J., Tachampa, K., Yuan, C., Jin, J. P., De Tombe, P. P., and Solaro, R. J. (2010). Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice. J. Biol. Chem. 285, 19688-19698. doi: 10.1074/jbc.M109.086892
17. Blumenschein, T. M. A., Tripet, B. P., Hodges, R. S., and Sykes, B. D. (2001). Mapping the interacting regions between troponins T and C: binding of TnT and TnI peptides to TnC and NMR mapping of the TnT-binding site on TnC. J. Biol. Chem. 276, 36606-36612. doi: 10.1074/jbc.M105130200
18. Bodor, G. S., Oakeley, A. E., Allen, P. D., Crimmins, D. L., Ladenson, J. H., and Anderson, P. A. W. (1997). Troponin I phosphorylation in the normal and failing adult human heart. Circulation 96, 1495-1500. doi: 10.1161/01.CIR.96.5.1495
19. Boral, M. C., and Deb, C. (1970). Seasonal changes in body fluids and haematology in toad Bufo melanostictus a poikilothermic cold torpor. Proc. Ind. Natl. Sci. Acad. 36, 369-379.
20. Burkart, E. M., Arteaga, G. M., Sumandea, M. P., Prabhakar, R., Wieczorek, D. F., and Solaro, R. J. (2003a). Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 35, 1285. doi: 10.1016/S0022-2828(03)00240-2
21. Burkart, E. M., Sumandea, M. P., Kobayashi, T., Nili, M., Martin, A. F., Homsher, E., et al. (2003b). Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J. Biol. Chem. 278, 11265-11272. doi: 10.1074/jbc.M210712200
22. Buscemi, N., Foster, D. B., Neverova, I., and Van Eyk, J. E. (2002). p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ. Res. 91, 509-516. doi: 10.1161/01.RES.0000035246.27856.53
23. Chandra, M., Montgomery, D. E., Kim, J. J., and Solaro, R. J. (1999). The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments. J. Mol. Cell. Cardiol. 31, 867-880. doi: 10.1006/jmcc.1999.0928
24. Chen, Z., Higashiyama, A., Yaku, H., Bell, S., Fabian, J., Watkins, M. W., et al. (1997). Altered expression of troponin T isoforms in mild left ventricular hypertrophy in the rabbit. J. Mol. Cell. Cardiol. 29, 2345. doi: 10.1006/jmcc.1997.0468
25. Chong, S. M., and Jin, J. P. (2009). To investigate protein evolution by detecting suppressed epitope structures. J. Mol. Evol. 68, 448-460. doi: 10.1007/s00239-009-9202-0
26. Collins, J. H. (1991). Myosin light chains and troponin C: structural and evolutionary relationships revealed by amino acid sequence comparisons. J. Muscle Res. Cell Motil. 12, 3-25. doi: 10.1007/BF01781170
27. Communal, C., Sumandea, M., De Tombe, P., Narula, J., Solaro, R. J., and Hajjar, R. J. (2002). Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 99, 6252-6256. doi: 10.1073/pnas.092022999
28. 2+ sensitivity in ventricular myocytes. Circ. Res. 100, 864-873. doi: 10.1161/01.RES.0000260809.15393.fa
29. 2+-independent mechanical tone and acute myocyte remodeling. Circ. Res. 100, 1494-1502. doi: 10.1161/01.RES.0000268412.34364.50
30. Deb, C., Chatterjee, S., and Boral, M. C. (1974). Body fluid and hematological changes in toads following heat exposure. Am. J. Physiol. 226, 408-410.
31. Di Lisa, F., De Tullio, R., Salamino, F., Barbato, R., Melloni, E., Siliprandi, N., et al. (1995). Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Biochem. J. 308, 57.
32. Du, J., Liu, J., Feng, H. Z., Hossain, M. M., Gobara, N., Zhang, C., et al. (2008). Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am. J. Physiol. Heart Circ. Physiol. 294, H2604-H2613. doi: 10.1152/ajpheart.91506.2007
33. Farah, C. S., Miyamoto, C. A., Ramos, C. H., Da Silva, A. C., Quaggio, R. B., Fujimori, K., et al. (1994). Structural and regulatory functions of the NH2- and COOH-terminal regions of skeletal muscle troponin I. J. Biol. Chem. 269, 5230-5240.
34. Feng, H. Z., Biesiadecki, B. J., Yu, Z. B., Hossain, M. M., and Jin, J. P. (2008a). Restricted N-terminal truncation of cardiac troponin T: a novel mechanism for functional adaptation to energetic crisis. J. Physiol. 586, 3537-3550. doi: 10.1113/jphysiol.2008.153577
35. Feng, H. Z., Chen, M., Weinstein, L. S., and Jin, J. P. (2008b). Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling. J. Biol. Chem. 283, 33384-33393. doi: 10.1074/jbc.M803302200
36. Feng, H. Z., Chen, X., Hossain, M. M., and Jin, J. P. (2012). Toad heart utilizes exclusively slow skeletal muscle troponin T: an evolutionary adaptation with potential functional benefits. J. Biol. Chem. 287, 29753-29764. doi: 10.1074/jbc.M112.373191
37. Feng, H. Z., Hossain, M. M., Huang, X. P., and Jin, J. P. (2009a). Myofilament incorporation determines the stoichiometry of troponin I in transgenic expression and the rescue of a null mutation. Arch. Biochem. Biophys. 487, 36-41. doi: 10.1016/j.abb.2009.05.001
38. Feng, H. Z., and Jin, J. P. (2010). Coexistence of cardiac troponin T variants reduces heart efficiency. Am. J. Physiol. Heart Circ. Physiol. 299, H97-H105. doi: 10.1152/ajpheart.01105.2009
39. Feng, H. Z., Wei, B., and Jin, J. P. (2009b). Deletion of a genomic segment containing the cardiac troponin I gene knocks down expression of the slow troponin T gene and impairs fatigue tolerance of diaphragm muscle. J. Biol. Chem. 284, 31798-31806. doi: 10.1074/jbc.M109.020826
40. Feng, J., Schaus, B. J., Fallavollita, J. A., Lee, T. C., and Canty, J. M. Jr., (2001). Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103, 2035-2037. doi: 10.1161/01.CIR.103.16.2035
41. Fentzke, R. C., Buck, S. H., Patel, J. R., Lin, H., Wolska, B. M., Stojanovic, M. O., et al. (1999). Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J. Physiol. 517, 143-157. doi: 10.1111/j.1469-7793.1999.0143z.x
42. Finley, N., Abbott, M. B., Abusamhadneh, E., Gaponenko, V., Dong, W., Gasmi-Seabrook, G., et al. (1999). NMR analysis of cardiac troponin C-troponin I complexes: effects of phosphorylation. FEBS Lett. 453, 107-112. doi: 10.1016/S0014-5793(99)00693-6
43. Flicker, P. F., Phillips, G. N. Jr., and Cohen, C. (1982). Troponin and its interactions with tropomyosin: an electron microscope study. J. Mol. Biol. 162, 495-501. doi: 10.1016/0022-2836(82)90540-X
44. Foster, D. B., Noguchi, T., Vanburen, P., Murphy, A. M., and Van Eyk, J. E. (2003). C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force implications for the pathophysiology of myocardial stunning. Circ. Res. 93, 917-924. doi: 10.1161/01.RES.0000099889.35340.6F
45. 2+-activated state of tropomyosin on actin filaments. Circ. Res. 106, 705-711. doi: 10.1161/CIRCRESAHA.109.210047
46. 2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J. Biol. Chem. 277, 35341-35349. doi: 10.1074/jbc.M204118200
47. Gomes, A. V., Liang, J., and Potter, J. D. (2005). Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J. Biol. Chem. 280, 30909-30915. doi: 10.1074/jbc.M500287200
48. Gomes, A. V., and Potter, J. D. (2004). Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene. Mol. Cell. Biochem. 263, 99-114. doi: 10.1023/B:MCBI.0000041852.42291.aa
49. Gordon, A., Homsher, E., and Regnier, M. (2000). Regulation of contraction in striated muscle. Physiol. Rev. 80, 853-924.
50. Grabarek, Z., Tao, T., and Gergely, J. (1992). Molecular mechanism of troponin-C function. J. Muscle Res. Cell Motil. 13, 383-393. doi: 10.1007/BF01738034
51. Greaser, M., and Gergely, J. (1971). Reconstitution of troponin activity from three protein components. J. Biol. Chem. 246, 4226-4233.
52. Guo, X., Wattanapermpool, J., Palmiter, K. A., Murphy, A. M., and Solaro, R. J. (1994). Mutagenesis of cardiac troponin I. Role of the unique NH2-terminal peptide in myofilament activation. J. Biol. Chem. 269, 15210-15216.
53. 2+ sensitivity of cardiac muscle contraction. J. Biol. Chem. 279, 14488-14495. doi: 10.1074/jbc.M309355200
54. Hastings, K. (1997). Molecular evolution of the vertebrate troponin I gene family. Cell Struct. Funct. 22:205. doi: 10.1247/csf.22.205
55. Haworth, R. S., Cuello, F., Herron, T. J., Franzen, G., Kentish, J. C., Gautel, M., et al. (2004). Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 95, 1091-1099. doi: 10.1161/01.RES.0000149299.34793.3c
56. He, X., Liu, Y., Sharma, V., Dirksen, R. T., Waugh, R., Sheu, S. S., et al. (2003). ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes. Am. J. Pathol. 163, 243-251. doi: 10.1016/S0002-9440(10)63647-4
57. Heeley, D., Golosinska, K., and Smillie, L. B. (1987). The effects of troponin T fragments T1 and T2 on the binding of nonpolymerizable tropomyosin to F-actin in the presence and absence of troponin I and troponin C. J. Biol. Chem. 262, 9971-9978.
58. Herzberg, O., and James, M. N. G. (1985). Structure of the calcium regulatory muscle protein troponin-C at 2.8 Å resolution. Nature 313, 653-659 doi: 10.1038/313653a0
59. Hinkle, A., Goranson, A., Butters, C. A., and Tobacman, L. S. (1999). Roles for the troponin tail domain in thin filament assembly and regulation: a deletion study of cardiac troponin T. J. Biol. Chem. 274, 7157-7164. doi: 10.1074/jbc.274.11.7157
60. Hoffmann, B., Schmidt-Traub, H., Perrot, A., Osterziel, K. J., and Gessner, R. (2001). First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum. Mutat. 17, 524-524. doi: 10.1002/humu.1143
61. Howarth, J. W., Meller, J., Solaro, R. J., Trewhella, J., and Rosevear, P. R. (2007). Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. J. Mol. Biol. 373, 706-722. doi: 10.1016/j.jmb.2007.08.035
62. Huang, Q. Q., Feng, H. Z., Liu, J., Du, J., Stull, L. B., Moravec, C. S., et al. (2008). Co-expression of skeletal and cardiac troponin T decreases mouse cardiac function. Am. J. Physiol. Cell Physiol. 294, C213-C222. doi: 10.1152/ajpcell.00146.2007
63. Iorga, B., Blaudeck, N., Solzin, J., Neulen, A., Stehle, I., Davila, A. J. L., et al. (2008). Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils. Cardiovasc. Res. 77, 676-686. doi: 10.1093/cvr/cvm113
64. Jeong, E. M., Wang, X., Xu, K., Hossain, M. M., and Jin, J. P. (2009). Nonmyofilament-associated troponin T fragments induce apoptosis. Am. J. Physiol. Heart Circ. Physiol. 297, H283-H292. doi: 10.1152/ajpheart.01200.2008
65. Jideama, N. M., Crawford, B. H., Hussain, A. K. M. A., and Raynor, R. L. (2006). Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T. Int. J. Biol. Sci. 2:1. doi: 10.7150/ijbs.2.1
66. Jideama, N. M., Noland, T. A. Jr. Raynor, R. L., Blobe, G. C., Fabbro, D., Kazanietz, M. G., et al. (1996). Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J. Biol. Chem. 271, 23277-23283. doi: 10.1074/jbc.271.38.23277
67. Jin, J. P. (1996). Alternative RNA splicing-generated cardiac troponin T isoform switching: a non-heart-restricted genetic programming synchronized in developing cardiac and skeletal muscles. Biochem. Biophys. Res. Commun. 225, 883-889. doi: 10.1006/bbrc.1996.1267
68. Jin, J. P., Chen, A., Ogut, O., and Huang, Q. Q. (2000). Conformational modulation of slow skeletal muscle troponin T by an NH(2)-terminal metal-binding extension. Am. J. Physiol. Cell Physiol. 279, C1067-C1077.
69. Jin, J. P., and Chong, S. M. (2010). Localization of the two tropomyosin-binding sites of troponin T. Arch. Biochem. Biophys. 500, 144-150. doi: 10.1016/j.abb.2010.06.001
70. Jin, J. P., Huang, Q. Q., Yeh, H. I., and Lin, J. J. (1992). Complete nucleotide sequence and structural organization of rat cardiac troponin T gene. A single gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J. Mol. Biol. 227, 1269-1276. doi: 10.1016/0022-2836(92)90540-Z
71. Jin, J. P., and Lin, J. J. (1988). Rapid purification of mammalian cardiac troponin T and its isoform switching in rat hearts during development. J. Biol. Chem. 263, 7309-7315.
72. Jin, J. P., and Lin, J. J. (1989). Isolation and characterization of cDNA clones encoding embryonic and adult isoforms of rat cardiac troponin T. J. Biol. Chem. 264, 14471-14477.
73. Jin, J. P., and Root, D. D. (2000). Modulation of troponin T molecular conformation and flexibility by metal ion binding to the NH2-terminal variable region. Biochemistry 39, 11702-11713. doi: 10.1021/bi9927437
74. Jin, J. P., and Smillie, L. B. (1994). An unusual metal-binding cluster found exclusively in the avian breast muscle troponin T of Galliformes and Craciformes. FEBS Lett. 341, 135-140. doi: 10.1016/0014-5793(94)80256-4
75. Jin, J. P., Wang, J., and Zhang, J. (1996). Expression of cDNAs encoding mouse cardiac troponin T isoforms: characterization of a large sample of independent clones. Gene 168, 217-221. doi: 10.1016/0378-1119(95)00803-9
76. 2+-modulated allosteric domain in the troponin complex. Biochemistry 40, 2623-2631. doi: 10.1021/bi002423j
77. Jin, J. P., Zhang, Z., and Bautista, J. A. (2008). Isoform diversity, regulation, and functional adaptation of troponin and calponin. Crit. Rev. Eukaryot Gene Expr. 18, 93-124. doi: 10.1615/CritRevEukarGeneExpr.v18.i2.10
78. Kamisago, M., Sharma, S. D., Depalma, S. R., Solomon, S., Sharma, P., McDonough, B., et al. (2000). Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med. 343, 1688-1696. doi: 10.1056/NEJM200012073432304
79. Kawasaki, H., Nakayama, S., and Kretsinger, R. (1998). Classification and evolution of EF-hand proteins. Biometals 11, 277-295. doi: 10.1023/A:1009282307967
80. Ke, Y., Lei, M., Wang, X., and Solaro, R. J. (2012). Novel roles of PAK1 in the heart. Cell. Logist. 2, 89-94. doi: 10.4161/cl.21497
81. Ke, Y., Wang, L., Pyle, W. G., De Tombe, P. P., and Solaro, R. J. (2004). Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ. Res. 94, 194-200. doi: 10.1161/01.RES.0000111522.02730.56
82. 2+ handling. Circ. Res. 89, 831-837. doi: 10.1161/hh2101.098547
83. Kimura, A., Harada, H., Park, J. E., Nishi, H., Satoh, M., Takahashi, M., et al. (1997). Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16, 379-382. doi: 10.1038/ng0897-379
84. 2+ affinity of the cardiac troponin complex. J. Exp. Biol. 214, 1981-1988. doi: 10.1242/jeb.052860
85. Kobayashi, T., Yang, X., Walker, L. A., Van Breemen, R. B., and Solaro, R. J. (2005). A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J. Mol. Cell. Cardiol. 38, 213-218. doi: 10.1016/j.yjmcc.2004.10.014
86. Kooij, V., Stienen, G. J. M., and Van Der Velden, J. (2011). The role of protein kinase C-mediated phosphorylation of sarcomeric proteins in the heart-detrimental or beneficial? Biophys. Rev. 3, 107-117. doi: 10.1007/s12551-011-0050-y
87. Kracklauer, M. P., Feng, H. Z., Jiang, W., Lin, J. L., Lin, J. J., and Jin, J. P. (2013). Discontinuous thoracic venous cardiomyocytes and heart exhibit synchronized developmental switch of troponin isoforms. FEBS J. 280, 880-891. doi: 10.1111/febs.12076
88. Lakdawala, N. K., Thune, J. J., Colan, S. D., Cirino, A. L., Farrohi, F., Rivero, J., et al. (2012). Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ. Cardiovasc. Genet. 5, 503-510. doi: 10.1161/CIRCGENETICS.112.962761
89. Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., et al. (2008). Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J. Mol. Cell. Cardiol. 45, 281-288. doi: 10.1016/j.yjmcc.2008.05.003
90. Layland, J., Li, J. M., and Shah, A. M. (2002). Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J. Physiol. 540, 457-467. doi: 10.1113/jphysiol.2001.014126
91. Layland, J., Solaro, R. J., and Shah, A. M. (2005). Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc. Res. 66, 12-21. doi: 10.1016/j.cardiores.2004.12.022
92. Li, D., Czernuszewicz, G. Z., Gonzalez, O., Tapscott, T., Karibe, A., Durand, J.-B., et al. (2001). Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 104, 2188-2193. doi: 10.1161/hc4301.098285
93. Li, M. X., Wang, X., Lindhout, D. A., Buscemi, N., Van Eyk, J. E., and Sykes, B. D. (2003). Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry 42, 14460-14468. doi: 10.1021/bi035408y
94. Li, M. X., Wang, X., and Sykes, B. D. (2004). Structural based insights into the role of troponin in cardiac muscle pathophysiology. J. Muscle Res. Cell Motil. 25, 559-579. doi: 10.1007/s10974-004-5879-2
95. 2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. J. Mol. Cell. Cardiol. 49, 402-411. doi: 10.1016/j.yjmcc.2010.04.017
96. Li, Y., Zhang, L., Jean-Charles, P. Y., Nan, C., Chen, G., Tian, J., et al. (2013). Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations. J. Mol. Cell. Cardiol. 62, 227-236. doi: 10.1016/j.yjmcc.2013.06.007
97. 2+ binding and myofilament contractility. Physiol. Genomics 33, 257-266. doi: 10.1152/physiolgenomics.00154.2007
98. Lim, C. C., Yang, H., Yang, M., Wang, C. K., Shi, J., Berg, E. A., et al. (2008). A novel mutant cardiac troponin C disrupts molecular motions critical for calcium binding affinity and cardiomyocyte contractility. Biophys. J. 94, 3577-3589. doi: 10.1529/biophysj.107.112896
99. Lindhout, D. A., Li, M. X., Schieve, D., and Sykes, B. D. (2002). Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C. Biochemistry 41, 7267-7274. doi: 10.1021/bi020100c
100. Liu, B., Lee, R. S., Biesiadecki, B. J., Tikunova, S. B., and Davis, J. P. (2012). Engineered Troponin C constructs correct disease-related cardiac myofilament calcium sensitivity. J. Biol. Chem. 287, 20027-20036. doi: 10.1074/jbc.M111.334953
101. Liu, R., Feng, H. Z., and Jin, J. P. (2014). Physiological contractility of cardiomyocytes in the wall of mouse and rat azygos vein. Am. J. Physiol. Cell Physiol. 306, C697-C704. doi: 10.1152/ajpcell.00004.2014
102. Lu, Q. W., Hinken, A. C., Patrick, S. E., Solaro, R. J., and Kobayashi, T. (2010). Phosphorylation of cardiac troponin I at protein kinase C site threonine 144 depresses cooperative activation of thin filaments. J. Biol. Chem. 285, 11810-11817. doi: 10.1074/jbc.M109.055657
103. Lüss, H., Meissner, A., Rolf, N., Van Aken, H., Bokník, P., Kirchhefer, U., et al. (2000). Biochemical mechanism (s) of stunning in conscious dogs. Am. J. Physiol. Heart Circ. Physiol. 279, H176-H184.
104. Macgowan, G. A., Du, C., Cowan, D. B., Stamm, C., McGowan, F. X., Solaro, R. J., et al. (2001). Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am. J. Physiol. Heart Circ. Physiol. 280, H835-H843.
105. Maron, B. J., Shirani, J., Poliac, L. C., Mathenge, R., Roberts, W. C., and Mueller, F. O. (1996). Sudden death in young competitive athletes. JAMA 276, 199-204. doi: 10.1001/jama.1996.03540030033028
106. Martin, A. F. (1981). Turnover of cardiac troponin subunits. Kinetic evidence for a precursor pool of troponin-I. J. Biol. Chem. 256, 964-968.
107. McConnell, B. K., Moravec, C. S., and Bond, M. (1998). Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 274, H385-H396.
108. McDonough, J. L., Arrell, D. K., and Van Eyk, J. E. (1999). Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ. Res. 84, 9-20. doi: 10.1161/01.RES.84.1.9
109. McDonough, J., Labugger, R., Pickett, W., Tse, M., Mackenzie, S., Pang, S., et al. (2001). Cardiac troponin I is modified in the myocardium of bypass patients. Circulation 103, 58-64. doi: 10.1161/01.CIR.103.1.58
110. Mesnard, L., Logeart, D., Taviaux, S., Diriong, S., Mercadier, J. J., and Samson, F. (1995). Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ. Res. 76, 687-692. doi: 10.1161/01.RES.76.4.687
111. Messer, A. E., Jacques, A. M., and Marston, S. B. (2007). Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J. Mol. Cell. Cardiol. 42, 247-259. doi: 10.1016/j.yjmcc.2006.08.017
112. Mirza, M., Marston, S., Willott, R., Ashley, C., Mogensen, J., McKenna, W., et al. (2005). Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype. J. Biol. Chem. 280, 28498-28506. doi: 10.1074/jbc.M412281200
113. Mogensen, J., Murphy, R. T., Shaw, T., Bahl, A., Redwood, C., Watkins, H., et al. (2004). Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 44, 2033-2040. doi: 10.1016/j.jacc.2004.08.027
114. Monasky, M. M., Taglieri, D. M., Patel, B. G., Chernoff, J., Wolska, B. M., Ke, Y., et al. (2012). p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 302, H224-H230. doi: 10.1152/ajpheart.00612.2011
115. Montgomery, D. E., Chandra, M., Huang, Q., Jin, J., and Solaro, R. J. (2001). Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am. J. Physiol. Heart Circ. Physiol. 280, H1011-H1018.
116. Morris, E. P., and Lehrer, S. S. (1984). Troponin-tropomyosin interactions. Fluorescence studies of the binding of troponin, troponin T and chymotryptic troponin T fragments to specifically labeled tropomyosin. Biochemistry 23, 2214-2220. doi: 10.1021/bi00305a018
117. Murphy, A. M. (2006). Heart failure, myocardial stunning, and troponin: a key regulator of the cardiac myofilament. Congest Heart Fail 12, 32-40. doi: 10.1111/j.1527-5299.2006.04320.x
118. Murphy, A. M., Kögler, H., Georgakopoulos, D., McDonough, J. L., Kass, D. A., Van Eyk, J. E., et al. (2000). Transgenic mouse model of stunned myocardium. Science 287, 488-491. doi: 10.1126/science.287.5452.488
119. Narolska, N. A., Piroddi, N., Belus, A., Boontje, N. M., Scellini, B., Deppermann, S., et al. (2006). Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ. Res. 99, 1012-1020. doi: 10.1161/01.RES.0000248753.30340.af
120. Nixon, B. R., Thawornkaiwong, A., Jin, J., Brundage, E. A., Little, S. C., Davis, J. P., et al. (2012). AMP-activated protein kinase phosphorylates cardiac Troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. J. Biol. Chem. 287, 19136-19147. doi: 10.1074/jbc.M111.323048
121. 2+-stimulated actomyosin MgATPase activity. J. Biol. Chem. 266, 4974-4978.
122. 2+-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J. Mol. Cell. Cardiol. 25, 53-65. doi: 10.1006/jmcc.1993.1007
123. Ogut, O., and Jin, J. P. (1996). Expression, zinc-affinity purification, and characterization of a novel metal-binding cluster in troponin T: metal-stabilized alpha-helical structure and effects of the NH2-terminal variable region on the conformation of intact troponin T and its association with tropomyosin. Biochemistry 35, 16581-16590. doi: 10.1021/bi961712y
124. Oliveira, S. M., Zhang, Y. H., Solis, R. S., Isackson, H., Bellahcene, M., Yavari, A., et al. (2012). AMP-activated protein kinase phosphorylates cardiac Troponin I and alters contractility of murine ventricular MyocytesNovelty and significance. Circ. Res. 110, 1192-1201. doi: 10.1161/CIRCRESAHA.111.259952
125. Palpant, N. J., Houang, E. M., Delport, W., Hastings, K. E. M., Onufriev, A. V., Sham, Y. Y., et al. (2010). Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations. Physiol. Genomics 42, 287-299. doi: 10.1152/physiolgenomics.00033.2010
126. Parvatiyar, M. S., Landstrom, A. P., Figueiredo-Freitas, C., Potter, J. D., Ackerman, M. J., and Pinto, J. R. (2012). A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation. J. Biol. Chem. 287, 31845-31855. doi: 10.1074/jbc.M112.377713
127. Perry, S. (1998). Troponin T: genetics, properties and function. J. Muscle Res. Cell Motil. 19, 575-602. doi: 10.1023/A:1005397501968
128. Perry, S. (1999). Troponin I: inhibitor or facilitator. Mol. Cell. Biochem. 190, 9-32. doi: 10.1023/A:1006939307715
129. Pfleiderer, P., Sumandea, M. P., Rybin, V. O., Wang, C., and Steinberg, S. F. (2009). Raf-1: a novel cardiac troponin T kinase. J. Muscle Res. Cell Motil. 30, 67-72. doi: 10.1007/s10974-009-9176-y
130. Pi, Y. Q., Kemnitz, K. R., Zhang, D., Kranias, E. G., and Walker, J. W. (2002). Phosphorylation of troponin I controls cardiac twitch dynamics evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ. Res. 90, 649-656. doi: 10.1161/01.RES.0000014080.82861.5F
131. 2+ sensitivity and ATPase activity in the mouse myocardium. J. Physiol. 552, 845-857. doi: 10.1113/jphysiol.2003.045260
132. Pinto, J. R., Parvatiyar, M. S., Jones, M. A., Liang, J., Ackerman, M. J., and Potter, J. D. (2009). A functional and structural study of Troponin C mutations related to hypertrophic cardiomyopathy. J. Biol. Chem. 284, 19090-19100. doi: 10.1074/jbc.M109.007021
133. Prigozy, T. I., Dalrymple, K., Shuler, C., and Kedes, L. (1997). Differential expression of troponin C genes during tongue myogenesis. Dev. Dyn. 209, 36-44.
134. Quirk, P. G., Patchell, V. B., Gao, Y., Levine, B. A., and Victor Perry, S. (1995). Sequential phosphorylation of adjacent serine residues on the N-terminal region of cardiac troponin-I: Structure-activity implications of ordered phosphorylation. FEBS Lett. 370, 175-178. doi: 10.1016/0014-5793(95)00812-N
135. Rao, V. S., Korte, F. S., Razumova, M. V., Feest, E. R., Hsu, H., Irving, T. C., et al. (2012). N-terminal phosphorylation of cardiac troponin-I reduces length dependent calcium sensitivity of contraction in cardiac muscle. J. Physiol. 591, 475-490. doi: 10.1113/jphysiol.2012.241604
136. Ricchiuti, V., and Apple, F. S. (1999). RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin. Chem. 45, 2129-2135.
137. 2+. Biophys. J. 34, 559-569. doi: 10.1016/S0006-3495(81)84868-0
138. Saggin, L., Gorza, L., Ausoni, S., and Schiaffino, S. (1989). Troponin I switching in the developing heart. J. Biol. Chem. 264, 16299-16302.
139. Sakthivel, S., Finley, N. L., Rosevear, P. R., Lorenz, J. N., Gulick, J., Kim, S., et al. (2005). In vivo and in vitro analysis of cardiac troponin I phosphorylation. J. Biol. Chem. 280, 703-714. doi: 10.1074/jbc.M409513200
140. Sancho Solis, R., Ge, Y., and Walker, J. W. (2008). Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry. J. Muscle Res. Cell Motil. 29, 203-212. doi: 10.1007/s10974-009-9168-y
141. Sancho Solis, R., Ge, Y., and Walker, J. W. (2011). A preferred AMPK phosphorylation site adjacent to the inhibitory loop of cardiac and skeletal troponin I. Protein Sci. 20, 894-907. doi: 10.1002/pro.623
142. Sasse, S., Brand, N., Kyprianou, P., Dhoot, G., Wade, R., Arai, M., et al. (1993). Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ. Res. 72, 932-938. doi: 10.1161/01.RES.72.5.932
143. Schaertl, S., Lehrer, S., and Geeves, M. (1995). Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation. Biochemistry 34, 15890-15894. doi: 10.1021/bi00049a003
144. Schmidtmann, A., Lindow, C., Villard, S., Heuser, A., Mügge, A., Geßner, R., et al. (2005). Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C. FEBS J. 272, 6087-6097. doi: 10.1111/j.1742-4658.2005.05001.x
145. Schreier, T., Kedes, L., and Gahlmann, R. (1990). Cloning, structural analysis, and expression of the human slow twitch skeletal muscle/cardiac troponin C gene. J. Biol. Chem. 265, 21247-21253.
146. Sehnert, A. J., Huq, A., Weinstein, B. M., Walker, C., Fishman, M., and Stainier, D. Y. R. (2002). Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat. Genet. 31, 106-110. doi: 10.1038/ng875
147. Seidman, J. G., and Seidman, C. (2001). The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104, 557-567. doi: 10.1016/S0092-8674(01)00242-2
148. Sfichi-Duke, L., Garcia-Cazarin, M. L., Sumandea, C. A., Sievert, G. A., Balke, C. W., Zhan, D. Y., et al. (2010). Cardiomyopathy-causing deletion K210 in cardiac troponin T alters phosphorylation propensity of sarcomeric proteins. J. Mol. Cell. Cardiol. 48, 934-942. doi: 10.1016/j.yjmcc.2010.01.005
149. 2+-specific sites of skeletal muscle TnC are required for full activity. J. Biol. Chem. 265, 21554-21560.
150. Sherman, A. J., Klocke, F. J., Decker, R. S., Decker, M. L., Kozlowski, K. A., Harris, K. R., et al. (2000). Myofibrillar disruption in hypocontractile myocardium showing perfusion-contraction matches and mismatches. Am. J. Physiol. Heart Circ. Physiol. 278, H1320-H1334.
151. Solaro, R. J. (2010). Sarcomere control mechanisms and the dynamics of the cardiac cycle. J. Biomed. Biotechnol. 2010:105648. doi: 10.1155/2010/105648
152. Solaro, R. J., and Kobayashi, T. (2011). Protein phosphorylation and signal transduction in cardiac thin filaments. J. Biol. Chem. 286, 9935-9940. doi: 10.1074/jbc.R110.197731
153. Solaro, R. J., Lee, J. A., Kentish, J. C., and Allen, D. G. (1988). Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ. Res. 63, 779-787. doi: 10.1161/01.RES.63.4.779
154. Solaro, R. J., Rosevear, P., and Kobayashi, T. (2008). The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem. Biophys. Res. Commun. 369, 82-87. doi: 10.1016/j.bbrc.2007.12.114
155. Solaro, R. J., and Van Der Velden, J. (2010). Why does troponin I have so many phosphorylation sites? Fact and fancy. J. Mol. Cell. Cardiol. 48, 810-816. doi: 10.1016/j.yjmcc.2010.02.014
156. Stelzer, J. E., Patel, J. R., Walker, J. W., and Moss, R. L. (2007). Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ. Res. 101, 503-511. doi: 10.1161/CIRCRESAHA.107.153650
157. Stevens, L., Bastide, B., Kischel, P., Pette, D., and Mounier, Y. (2002). Time-dependent changes in expression of troponin subunit isoforms in unloaded rat soleus muscle. Am. J. Physiol. Cell Physiol. 282, C1025-C1030. doi: 10.1152/ajpcell.00252.2001
158. Sumandea, M. P., Pyle, W. G., Kobayashi, T., De Tombe, P. P., and Solaro, R. J. (2003). Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J. Biol. Chem. 278, 35135-35144. doi: 10.1074/jbc.M306325200
159. Sumandea, M. P., Vahebi, S., Sumandea, C. A., Garcia-Cazarin, M. L., Staidle, J., and Homsher, E. (2009). Impact of cardiac troponin T N-terminal deletion and phosphorylation on myofilament function. Biochemistry 48, 7722-7731. doi: 10.1021/bi900516n
160. 2+-binding sites in cardiac/slow skeletal muscle troponin C perform distinct functions: site I alone cannot trigger contraction. Proc. Natl. Acad. Sci. U.S.A. 87, 9538-9542. doi: 10.1073/pnas.87.24.9538
161. Taglieri, D. M., Monasky, M. M., Knezevic, I., Sheehan, K. A., Lei, M., Wang, X., et al. (2011). Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. J. Mol. Cell. Cardiol. 51, 988-996. doi: 10.1016/j.yjmcc.2011.09.016
162. 2+-saturated form. Nature 424, 35-41. doi: 10.1038/nature01780
163. Tanokura, M., Tawada, Y., Ono, A., and Ohtsuki, I. (1983). Chymotryptic subfragments of troponin T from rabbit skeletal muscle. Interaction with tropomyosin, troponin I and troponin C. J. Biochem. (Tokyo) 93, 331-337.
164. Tardiff, J. C., Factor, S. M., Tompkins, B. D., Hewett, T. E., Palmer, B. M., Moore, R. L., et al. (1998). A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J. Clin. Invest. 101, 2800. doi: 10.1172/JCI2389
165. Thierfelder, L., Watkins, H., Macrae, C., Lamas, R., McKenna, W., Vosberg, H.-P., et al. (1994). a-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77, 701-712. doi: 10.1016/0092-8674(94)90054-X
166. Thomas, S. A., Fallavollita, J. A., Lee, T. C., Feng, J., and Canty, J. M. (1999). Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine. Circ. Res. 85, 446-456. doi: 10.1161/01.RES.85.5.446
167. Townsend, P. J., Barton, P. J., Yacoub, M. H., and Farza, H. (1995). Molecular cloning of human cardiac troponin T isoforms: expression in developing and failing heart. J. Mol. Cell. Cardiol. 27, 2223-2236. doi: 10.1016/S0022-2828(95)91587-7
168. Vahebi, S., Kobayashi, T., Warren, C. M., De Tombe, P. P., and Solaro, R. J. (2005). Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ. Res. 96, 740-747. doi: 10.1161/01.RES.0000162457.56568.7d
169. Van Der Velden, J., Merkus, D., Klarenbeek, B., James, A., Boontje, N., Dekkers, D., et al. (2004). Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ. Res. 95, e85-e95. doi: 10.1161/01.RES.0000149531.02904.09
170. Van Eerd, J. P., and Takahashi, K. (1976). Determination of the complete amino acid sequence of bovine cardiac troponin C. Biochemistry 15, 1171-1180. doi: 10.1021/bi00650a033
171. Varnava, A. M., Elliott, P. M., Baboonian, C., Davison, F., Davies, M. J., and McKenna, W. J. (2001). Hypertrophic cardiomyopathy histopathological features of sudden death in cardiac Troponin T disease. Circulation 104, 1380-1384. doi: 10.1161/hc3701.095952
172. 2+-regulated structural changes in troponin. Proc. Natl. Acad. Sci. U.S.A. 102, 5038-5043. doi: 10.1073/pnas.0408882102
173. 2+-sensitizing mutation. Biochemistry 51, 4473-4487. doi: 10.1021/bi3003007
174. 2+ by phosphorylating troponin I on threonine-144. J. Mol. Cell. Cardiol. 41, 823. doi: 10.1016/j.yjmcc.2006.08.016
175. Wang, J., and Jin, J. P. (1998). Conformational modulation of troponin T by configuration of the NH2-terminal variable region and functional effects. Biochemistry 37, 14519-14528. doi: 10.1021/bi9812322
176. Wang, X., Huang, Q. Q., Breckenridge, M. T., Chen, A., Crawford, T. O., Morton, D. H., et al. (2005). Cellular fate of truncated slow skeletal muscle troponin T produced by Glu180 nonsense mutation in amish nemaline myopathy. J. Biol. Chem. 280, 13241-13249. doi: 10.1074/jbc.M413696200
177. Wang, Y., Pinto, J. R., Solis, R. S., Dweck, D., Liang, J., Diaz-Perez, Z., et al. (2012b). Generation and functional characterization of knock-in mice harboring the cardiac Troponin I-R21C mutation associated with hypertrophic cardiomyopathy. J. Biol. Chem. 287, 2156-2167. doi: 10.1074/jbc.M111.294306
178. Ward, A. J., and Cooper, T. A. (2010). The pathobiology of splicing. J. Pathol. 220, 152-163. doi: 10.1002/path.2649
179. Watkins, H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'donoghue, A., et al. (1995). Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058-1065.
180. Wei, B., Gao, J., Huang, X. P., and Jin, J. P. (2010). Mutual rescues between two dominant negative mutations in cardiac troponin I and cardiac troponin T. J. Biol. Chem. 285, 27806-27816. doi: 10.1074/jbc.M110.137844
181. Wei, B., and Jin, J. P. (2011). Troponin T isoforms and posttranscriptional modifications: evolution, regulation and function. Arch. Biochem. Biophys. 505, 144-154. doi: 10.1016/j.abb.2010.10.013
182. Wei, H., and Jin, J. P. (2013). N-terminal truncated cardiac troponin I enhanced the contractility of isolated cardiomyocytes. Biophys. J. 104, 154a-155a. doi: 10.1016/j.bpj.2012.11.875
183. Westfall, M. V., Albayya, F. P., and Metzger, J. M. (1999). Functional analysis of troponin I regulatory domains in the intact myofilament of adult single cardiac myocytes. J. Biol. Chem. 274, 22508-22516. doi: 10.1074/jbc.274.32.22508
184. 2+-activated myofilament tension in adult cardiac myocytes. Circ. Res. 86, 470-477. doi: 10.1161/01.RES.86.4.470
185. Westfall, M. V., Lee, A. M., and Robinson, D. A. (2005). Differential contribution of Troponin I phosphorylation sites to the endothelin-modulated contractile response. J. Biol. Chem. 280, 41324-41331. doi: 10.1074/jbc.M506043200
186. White, S. P., Cohen, C., and Phillips, G. N. Jr. (1987). Structure of co-crystals of tropomyosin and troponin. Nature 325, 826-828 doi: 10.1038/325826a0
187. Willott, R. H., Gomes, A. V., Chang, A. N., Parvatiyar, M. S., Pinto, J. R., and Potter, J. D. (2010). Mutations in Troponin that cause HCM, DCM AND RCM: What can we learn about thin filament function? J. Mol. Cell. Cardiol. 48, 882-892. doi: 10.1016/j.yjmcc.2009.10.031
188. You, B., Yan, G., Zhang, Z., Yan, L., Li, J., Ge, Q., et al. (2009). Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1. Biochem. J. 418, 93-101. doi: 10.1042/BJ20081340
189. Yu, Z. B., Gao, F., Feng, H. Z., and Jin, J. P. (2007). Differential regulation of myofilament protein isoforms underlying the contractility changes in skeletal muscle unloading. Am. J. Physiol. Cell Physiol. 292, C1192-C1203. doi: 10.1152/ajpcell.00462.2006
190. Yu, Z. B., Wei, H., and Jin, J. P. (2012). Chronic coexistence of two troponin T isoforms in adult transgenic mouse cardiomyocytes decreased contractile kinetics and caused dilatative remodeling. Am. J. Physiol. Cell Physiol. 303, C24-C32. doi: 10.1152/ajpcell.00026.2012
191. Yu, Z. B., Zhang, L. F., and Jin, J. P. (2001). A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity. J. Biol. Chem. 276, 15753-15760. doi: 10.1074/jbc.M011048200
192. 2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem. Biophys. Res. Commun. 338, 1519-1526. doi: 10.1016/j.bbrc.2005.10.116
193. Zakhary, D. R., Moravec, C. S., Stewart, R. W., and Bond, M. (1999). Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 99, 505-510. doi: 10.1161/01.CIR.99.4.505
194. Zhang, P., Kirk, J. A., Ji, W., Dos Remedios, C. G., Kass, D. A., Van Eyk, J. E., et al. (2012). Multiple reaction monitoring to identify site-specific Troponin I phosphorylated residues in the failing human heart/clinical perspective. Circulation 126, 1828-1837. doi: 10.1161/CIRCULATIONAHA.112.096388
195. Zhang, R., Zhao, J., Mandveno, A., and Potter, J. D. (1995a). Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ. Res. 76, 1028-1035. doi: 10.1161/01.RES.76.6.1028
196. Zhang, R., Zhao, J. J., and Potter, J. D. (1995b). Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca affinity of cardiac troponin C. J. Biol. Chem. 270, 30773-30780. doi: 10.1074/jbc.270.51.30773
197. Zhang, Z., Akhter, S., Mottl, S., and Jin, J. P. (2011a). Calcium-regulated conformational change in the C-terminal end segment of troponin I and its binding to tropomyosin. FEBS J. 278, 3348-3359. doi: 10.1111/j.1742-4658.2011.08250.x
198. Zhang, Z., Biesiadecki, B. J., and Jin, J. P. (2006). Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage. Biochemistry 45, 11681-11694. doi: 10.1021/bi060273s
199. Zhang, Z., Feng, H. Z., and Jin, J. P. (2011b). Structure of the NH2-terminal variable region of cardiac troponin T determines its sensitivity to restrictive cleavage in pathophysiological adaptation. Arch. Biochem. Biophys. 515, 37-45. doi: 10.1016/j.abb.2011.08.013
200. 2+ sites on troponin C in the regulation of muscle contraction. Preparation and properties of troponin C depleted myofibrils. J. Biol. Chem. 257, 7678-7683.